# ASSURE WCD Clinical Evaluation - Conversion Efficacy Study

> **NCT04132466** · NA · COMPLETED · sponsor: **Kestra Medical Technologies, Inc.** · enrollment: 13 (actual)

## Conditions studied

- Death, Sudden, Cardiac

## Interventions

- **DEVICE:** Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system

## Key facts

- **NCT ID:** NCT04132466
- **Lead sponsor:** Kestra Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-25
- **Primary completion:** 2020-03-19
- **Final completion:** 2020-03-19
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04132466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04132466, "ASSURE WCD Clinical Evaluation - Conversion Efficacy Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04132466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*